Candesartan
ADVERTISEMENT
- Molecular formula
- C24H20N6O3
- CAS Number
- 139481-59-7
- IUPAC Name
- 2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one
- Molecular Weight
- 610.66g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.3600g/cm3
- Synonyms
- irbesartan
Identification
Interesting facts
Interesting Facts about 2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one
This compound, with its intricate structure, represents a fascinating area of study in modern chemistry, particularly in medicinal and pharmaceutical fields. Here are some notable aspects:
- Spirans and Scaffold Chemistry: The spirocyclic framework in 2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one introduces unique three-dimensional properties that can significantly affect biological activity. Such scaffolds are often examined for their ability to interact with biological targets.
- Tetrazole Moiety: The presence of the tetrazole ring is particularly exciting as compounds containing this moiety are known for their diverse pharmacological activities—including anti-inflammatory and antibacterial properties. The tetrazole's ability to mimic carboxylic acids makes it a valuable asset in drug design.
- Synthetic Versatility: Due to its complex structure, the synthesis of this compound could involve various organic reactions, showcasing the versatility of organic synthesis techniques, from coupling reactions to cycloadditions. Such synthetic routes are essential for developing new medications.
- Biological Engagement: Structurally complex compounds like this one can be screened for biological activity, leading to the potential development of new therapeutics. The specific arrangement of functional groups may influence the compound's binding affinity to target proteins.
- Multifunctionality: The combination of both diaza and spirocyclic elements in this molecule suggests potential multifunctional characteristics, allowing it to interact with multiple biological pathways. This characteristic is critical for compounds intended for advanced therapeutic interventions.
Moreover, ongoing research into compounds like 2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one could lead to breakthroughs in understanding complex diseases and developing novel treatments.